Program Evaluation of People With Arthritis Can Exercise
NCT ID: NCT00153309
Last Updated: 2005-11-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2/PHASE3
320 participants
INTERVENTIONAL
2003-06-30
2005-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Identify the theoretical foundations and constructs for evaluating the program and select and use appropriate outcome measures;
2. Plan and conduct a randomized controlled trial of 8 and 16 week PACE programs;
3. Perform a qualitative evaluation using focus groups of PACE instructors and participants;
4. Disseminate findings and make recommendations.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
People with Arthritis Can Exercise
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Self-reported arthritis or chronic joint symptoms
* Community-dwelling
Exclusion Criteria
* No severe physical or mental condition
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Missouri-Columbia
OTHER
St. Louis University
OTHER
Centers for Disease Control and Prevention
FED
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jennifer M Hootman, PhD
Role: STUDY_DIRECTOR
Centers for Disease Control and Prevention
Marian Minor, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Missouri-Columbia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
St. Louis University
St Louis, Missouri, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CDC-NCCDPHP-MM-0507
Identifier Type: -
Identifier Source: secondary_id
CDC-NCCDPHP-0507
Identifier Type: -
Identifier Source: org_study_id